chr22-45414002-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015653.5(RIBC2):āc.116A>Gā(p.Asn39Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,551,558 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152142Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000520 AC: 8AN: 153960Hom.: 1 AF XY: 0.0000490 AC XY: 4AN XY: 81686
GnomAD4 exome AF: 0.0000157 AC: 22AN: 1399298Hom.: 0 Cov.: 32 AF XY: 0.00000724 AC XY: 5AN XY: 690152
GnomAD4 genome AF: 0.000197 AC: 30AN: 152260Hom.: 1 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.101A>G (p.N34S) alteration is located in exon 1 (coding exon 1) of the RIBC2 gene. This alteration results from a A to G substitution at nucleotide position 101, causing the asparagine (N) at amino acid position 34 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at